What we do have is a growing body of laboratory and animal research, early clinical experience, and a clearer understanding of the questions that still need to be answered
Q9: Is BPC-157 dangerous
REDEFINE 2 (obesity with type 2 diabetes) A phase 3a, 68-week, double-blind, placebo-controlled trial across 12 countries (NCT05394519 [11] ) in 1,206 adults with BMI 27, HbA 1c 710%, and type 2 diabetes, randomised 3:1 to CagriSema 2.4/2.4 mg (n=904) or placebo (n=302)
A few report slight increases, possibly related to compensatory responses or anxiety about self-injection
Our lipotropic injections are administered in our office and used in conjunction with other aspects of your weight loss plan for the best results
For a more personal touch, our telehealth video visits connect you with our doctors 24/7, in all 50 states, for less than $40